https://scholars.lib.ntu.edu.tw/handle/123456789/627204
標題: | Overall survival and objective response in advanced unresectable hepatocellular carcinoma: A subanalysis of the REFLECT study | 作者: | Kudo, Masatoshi Finn, Richard S Qin, Shukui Han, Kwang-Hyub Ikeda, Kenji ANN-LII CHENG Vogel, Arndt Tovoli, Francesco Ueshima, Kazuomi Aikata, Hiroshi López, Carlos López Pracht, Marc Meng, Zhiqiang Daniele, Bruno Park, Joong-Won Palmer, Daniel Tamai, Toshiyuki Saito, Kenichi Dutcus, Corina E Lencioni, Riccardo |
關鍵字: | landmark analysis; lenvatinib; mRECIST; response status; surrogate endpoint | 公開日期: | 一月-2023 | 卷: | 78 | 期: | 1 | 來源出版物: | Journal of hepatology | 摘要: | Validated surrogate endpoints for overall survival (OS) are important for expediting the clinical study and drug-development processes. Herein, we aimed to validate objective response as an independent predictor of OS in individuals with unresectable hepatocellular carcinoma (HCC) receiving systemic anti-angiogenic therapy. |
URI: | https://scholars.lib.ntu.edu.tw/handle/123456789/627204 | ISSN: | 01688278 | DOI: | 10.1016/j.jhep.2022.09.006 |
顯示於: | 腫瘤醫學研究所 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。